Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eleven Biotherapeutics, US based developer of protein-based therapeutics, has named Abbie Celniker as the CEO.
Subscribe to our email newsletter
Most recently, Celniker worked as the president and CEO of Taligen Therapeutics.
Before joining Taligen, Celniker was global head of biologics at Novartis, where she oversaw the biologics division, forged strategic alliances and led internal discovery and development to build the pipeline.
Prior to Novartis, she worked for Millennium Pharmaceuticals as senior vice president, R&D strategy and operations and head of biotherapeutics and pharmaceutical sciences.